Did You Know...
...that to encourage use of his new invention, the shopping cart, market owner Sylvan Goldman hired fake shoppers to push the carts around his store in Oklahoma City? Seems his customers were reluctant to give up their hand-carried baskets.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 6361938 | Peptides which enhance transport across tissues and methods of identifying and using the same A method of identifying a peptide which permits or facilitates the transport of an active agent through a human or animal tissue. A predetermined amount of phage from a random phage library or a preselected phage library is administered in vivo or in situ... | 03/26/2002 |
| 6110494 | Cisapride mini-tablet formulations A sustained release cisapride oral dosage formulation suitable for once-daily administration comprises a plurality of mini-tablets containing cisapride or a salt thereof with an organic acid and capable of releasing cisapride at different sites along the ... | 08/29/2000 |
| 6066339 | Oral morphine multiparticulate formulation An oral morphine multiparticulate formulation for once-daily administration to a patient, comprising sustained release particles each having a core containing water soluble morphine and an osmotic agent, the core being coated with a rate-controlling polym... | 05/23/2000 |
| 5637320 | Controlled absorption naproxen formulation for once-daily administration A once-daily naproxen formulation for oral administration having a first portion of the naproxen as a multi-particulate pellet form, each pellet having a core of naproxen or a pharmaceutically acceptable salt thereof in association with an organic acid, t... | 06/10/1997 |
| 5616345 | Controlled absorption diltiazen formulation for once-daily administration A diltiazem pellet formulation for oral administration comprises a core of diltiazem or a pharmaceutically acceptable salt thereof in association with an organic acid, and a multi-layer membrane surrounding the core and containing a major proportion of a ... | 04/01/1997 |
| 5580580 | Formulations and their use in the treatment of neurological diseases Pharmaceutical formulations comprise a mono- or di-aminopyridine active agent for administration on a once- or twice-daily basis for use in the treatment of neurological diseases, in particular multiple sclerosis and Alzheimer's disease. The formulations,... | 12/03/1996 |
| 5540938 | Formulations and their use in the treatment of neurological diseases Pharmaceutical formulations comprise a mono- or di-aminopyridine active agent for administration on a once- or twice-daily basis for use in the treatment of neurological diseases, in particular multiple sclerosis and Alzheimer's disease. The formulations,... | 07/30/1996 |
| 5533995 | Passive transdermal device with controlled drug delivery A transdermal device for the controlled administration of a drug to the skin comprises a reservoir (12) for the drug and an electric circuit which includes an electrode system (13, 14) which is operable to actively transport the drug in a controlled manne... | 07/09/1996 |
| 5370879 | Formulations and their use in the treatment of neurological diseases Pharmaceutical formulations comprise a mono- or di-aminopyridine active agent for administration on a once- or twice-daily basis for use in the treatment of neurological diseases, in particular multiple sclerosis and Alzheimer's disease. The formulations,... | 12/06/1994 |
| 5364620 | Controlled absorption diltiazem formulation for once daily administration A diltiazem pellet formulation for oral administration comprises a core of diltiazem or a pharmaceutically acceptable salt thereof in association with an organic acid, and a multi-layer membrane surrounding the core and containing a major proportion of a ... | 11/15/1994 |
| 5354556 | Controlled release powder and process for its preparation A controlled release powder containing discrete micro-particles for use in edible, pharmaceutical and other controlled release compositions is disclosed. The micro-particles have an average size in the range of from 0.1 to 125 μm. Each of the micro-parti... | 10/11/1994 |
| 5336504 | Diltiazem formulations and methods of treatment A diltiazem pellet formulation for oral administration comprises a core of diltiazem or a pharmaceutically acceptable salt thereof in association with an organic acid, and a multi-layer membrane surrounding the core and containing a major proportion of a ... | 08/09/1994 |
| 5332113 | Cap assembly A cap assembly for an enteral feeding container having an inner and outer cap. The inner cap has an upper end forming a tray with an inner peripheral lip and an outer peripheral lip, A flexible inner membrane covers the inner side of the tray of the inner... | 07/26/1994 |
| 5298257 | Method for the treatment of withdrawal symptoms associated with smoking cessation and preparations for use in said method A preparation for the once-daily, percutaneous administration of nicotine comprises nicotine uniformly distributed in a solid, semi-solid or mucilaginous medium which can be placed in intimate contact with the skin, the solid, semi-solid or mucilaginous m... | 03/29/1994 |
| 5219621 | Methods of treatment with diltiazem formulations A diltiazem pellet formulation for oral administration comprises a core of diltiazem or a pharmaceutically acceptable salt thereof in association with an organic acid, and a multi-layer membrane surrounding the core and containing a major proportion of a ... | 06/15/1993 |
| 5156842 | Liquid suspension for oral administration A non-aqueous pharmaceutical liquid suspension having improved bioavailability for oral administration comprises an active ingredient suspended in an edible, non-aqueous carrier vehicle such as an oil, wherein the active ingredient is in the form of contr... | 10/20/1992 |
| 5135480 | Transdermal drug delivery device A transdermal device having a detachably mounted electrode with a first surface adapted for contact with human skin and through which a drug substance contained in the electrode passes to the skin under the influence of an iontophoretic or electro-osmotic... | 08/04/1992 |
| 5069904 | Method of using nicotine in the treatment of conditions susceptible to said treatment A method of using nicotine in the treatment of various conditions susceptible to alleviation by nicotine therapy such as disease states characterized by reduced central cholinergic function. Nicotine is administered to a subject initially having a blood s... | 12/03/1991 |
| 5002776 | Controlled absorption diltiazem formulations A controlled absorption diltiazem pellet formulation for oral administration comprises a core of diltiazem or a pharmaceutically acceptable salt thereof in association with an organic acid, and a multi-layer membrane surrounding the core and containing a ... | 03/26/1991 |
| 4973469 | Drug delivery system A controlled release formulation comprising an adsorbate of a mixture of a pharmaceutically useful active ingredient and an inactive substance adsorbed on a cross-linked polymer. The inactive substance is selected to modify the dissolution of the active i... | 11/27/1990 |
| 4956355 | Agents for the arrest and therapy of retroviral infections Compounds of the general Formula (I) ##STR1## in which R is a hydrogen atom or a bromine atom, and R1 is a hydrogen atom, an SO2 OM group wherein M is a hydrogen or sodium atom, various sulphatide or phosphatide groups or a gluc... | 09/11/1990 |
| 4946853 | Method for the treatment of withdrawal symptoms associated with smoking cessation and preparations for use in said method A preparation for the once-daily, percutaneous administration of nicotine comprises nicotine uniformly distributed in a solid, semi-solid or mucilaginous medium which can be placed in intimate contact with the skin, the solid, semi-solid or mucilaginous m... | 08/07/1990 |
| 4863742 | Controlled absorption pharmaceutical composition A controlled absorption verapamil containing pellet formulation for oral adminstration comprises a core of a powder mixture containing verapamil or a pharmaceutically acceptable salt thereof and an organic acid and a polymeric material, said core comprisi... | 09/05/1989 |
| 4435508 | Tissue culture vessel The tissue culture vessel of this invention comprises two rigid plates with aligned apertures. The upper plate is separated from the lower plate by a rubber gasket and an interchangeable growth substrate. The two plates are held together with screws. Mate... | 03/06/1984 |
